Early Imaging and Molecular Changes with Neoadjuvant Bevacizumab in Stage II/III Breast Cancer

SIMPLE SUMMARY: New blood vessel formation (angiogenesis) has a crucial role in tumour growth and spread. Bevacizumab is an anticancer therapy that targets angiogenesis by inhibiting the vascular endothelial growth factor (VEGF) and is approved for the treatment of metastatic breast cancer. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Vega, José Manuel, Álvarez, Isabel, Antón, Antonio, Illarramendi, José Juan, Llombart, Antonio, Boni, Valentina, García-Velloso, María José, Martí-Climent, Josep María, Pina, Luis, García-Foncillas, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307791/
https://www.ncbi.nlm.nih.gov/pubmed/34298725
http://dx.doi.org/10.3390/cancers13143511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307791/
https://www.ncbi.nlm.nih.gov/pubmed/34298725
http://dx.doi.org/10.3390/cancers13143511

Ejemplares similares